Your browser doesn't support javascript.
loading
Enhancing antigenic peptide discovery: Improved MHC-I binding prediction and methodology.
Gizinski, Stanislaw; Preibisch, Grzegorz; Kucharski, Piotr; Tyrolski, Michal; Rembalski, Michal; Grzegorczyk, Piotr; Gambin, Anna.
  • Gizinski S; Deepflare, Warsaw, Poland.
  • Preibisch G; Deepflare, Warsaw, Poland; University of Warsaw, Department of Mathematics Informatics and Mechanics, Warsaw, Poland. Electronic address: gpreibisch@deepflare.ai.
  • Kucharski P; Deepflare, Warsaw, Poland.
  • Tyrolski M; Deepflare, Warsaw, Poland.
  • Rembalski M; Deepflare, Warsaw, Poland.
  • Grzegorczyk P; Deepflare, Warsaw, Poland.
  • Gambin A; University of Warsaw, Department of Mathematics Informatics and Mechanics, Warsaw, Poland. Electronic address: a.gambin@uw.edu.pl.
Methods ; 224: 1-9, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38295891
ABSTRACT
The Major Histocompatibility Complex (MHC) is a critical element of the vertebrate cellular immune system, responsible for presenting peptides derived from intracellular proteins. MHC-I presentation is pivotal in the immune response and holds considerable potential in the realms of vaccine development and cancer immunotherapy. This study delves into the limitations of current methods and benchmarks for MHC-I presentation. We introduce a novel benchmark designed to assess generalization properties and the reliability of models on unseen MHC molecules and peptides, with a focus on the Human Leukocyte Antigen (HLA)-a specific subset of MHC genes present in humans. Finally, we introduce HLABERT, a pretrained language model that outperforms previous methods significantly on our benchmark and establishes a new state-of-the-art on existing benchmarks.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Proteínas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Proteínas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article